Financials
- Market Capitalization 1.33 B
- Employee 110
- Founded 2024
- CEO N/A
- Website www.inhibrx.com
- Headquarter Delaware, United States
- FIGI BBG01MS5Q9G3
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-8.74
Fiyat/satışlar oranı
941.13
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2208 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 4.14 USD | -7.80% | -8.81% | -17.20% | -17.03% | 1.35 B USD | ||
| 2214 | ANAB AnaptysBio, Inc. - Common Stock | 46.04 USD | +0.20% | -6.82% | -15.63% | +30.80% | 1.34 B USD | ||
| 2252 | DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.26 USD | -1.04% | -4.81% | +1.06% | +264.71% | 1.26 B USD | ||
| 2257 | GHRS GH Research PLC - Ordinary Shares | 20.02 USD | -5.16% | -9.94% | -26.40% | +41.38% | 1.24 B USD |